Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo

Measurement of plasma levels of two secreted platelet proteins (beta- thromboglobulin and platelet factor 4) has been suggested as a means for detecting increased platelet activation in vivo. A crucial question in the measurement is the distinction between in vivo and in vitro secretion of the proteins. One approach to this distinction is the measurement of both proteins in each sample. These proteins are present in platelets in similar amounts and are released in similar quantities, but the plasma levels of beta-thromboglobulin exceed the plasma levels of platelet factor 4. This difference in plasma level is presumably due to more rapid removal of platelet factor 4 from the plasma level, and there is suggestive evidence that the rapid removal of released platelet factor 4 is due to its binding to endothelial cells. It appears that when there is increased release of beta-thromboglobulin and platelet factor 4 in vivo, there is an increase in the ratio of plasma beta-thromboglobulin to plasma platelet factor 4 compared to that found in normal individuals, whereas when in vitro release is responsible for elevated levels, the ratio decreases. Thus measurements of both proteins in each blood sample will allow distinction between in vivo release and artefactual in vitro release.

[1]  L. Edmunds,et al.  In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta). , 1980, Blood.

[2]  J. Musial,et al.  Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. , 1980, The Journal of laboratory and clinical medicine.

[3]  D. Pepper,et al.  Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. , 1980, Thrombosis research.

[4]  F. Kueppers,et al.  Identification and separation of secreted platelet proteins by isoelectric focusing. Evidence that low-affinity platelet factor 4 is converted to beta-thromboglobulin by limited proteolysis. , 1980, Blood.

[5]  T. Martin,et al.  Human β-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells , 1979, Nature.

[6]  R. Canfield,et al.  Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. , 1979, The Journal of clinical investigation.

[7]  D. Pepper,et al.  Complete covalent structure of human beta-thromboglobulin. , 1978, Biochemistry.

[8]  M. Drillings,et al.  Radioimmunoassay of Platelet Factor 4 and β‐Thromboglobulin: Development and Application to Studies of Platelet Release in Relation to Fibrinopeptide A Generation , 1978, British journal of haematology.

[9]  D. Pepper,et al.  The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4. , 1978, Thrombosis research.

[10]  M. Lesch,et al.  Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. , 1978, The Journal of laboratory and clinical medicine.

[11]  L. McCoy,et al.  Primary structure of human platelet factor 4. , 1977, Thrombosis research.

[12]  S. P. Levine,et al.  Development of a radioimmunoassay for human platelet factor 4. , 1977, Thrombosis research.

[13]  K. Kurachi,et al.  Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. , 1977, The Journal of biological chemistry.

[14]  R. Hardy,et al.  Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.

[15]  J. Schulman,et al.  Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency. , 1976, The New England journal of medicine.

[16]  C. Ludlam,et al.  Three Approaches to the Radioimmunoassay of Human β‐Thromboglobulin , 1976 .

[17]  D. Pepper,et al.  Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. , 1975, Biochimica et biophysica acta.

[18]  R. Ross,et al.  Homocystinemia. Vascular injury and arterial thrombosis. , 1974, The New England journal of medicine.

[19]  P. Steele,et al.  Platelet Function Studies in Coronary Artery Disease , 1973, Circulation.

[20]  K. Kaplan,et al.  Radioimmunoassay of platelet factor 4. , 1982, Methods in enzymology.

[21]  E. Ritz,et al.  Beta-thromboglobulin is elevated in renal failure without thrombosis. , 1980, Thrombosis research.

[22]  Kaplan,et al.  Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. , 1979, Blood.

[23]  A. Budzynski,et al.  Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay. , 1979, Blood.

[24]  D. Pepper,et al.  Binding of Platelet Factor 4 to Cultured Human Endothelial Cells , 1979, Thrombosis and Haemostasis.

[25]  K. Kaplan.  Proteins secreted by platelets: significance in detecting thrombosis. , 1978, Advances in experimental medicine and biology.

[26]  J. Ritchie,et al.  Platelet and fibrinogen survival in coronary atherosclerosis , 1977 .